| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/10/2008 | CA2664399A1 Use of hypothermia inducing drugs |
| 01/10/2008 | CA2656851A1 Substituted cinnamoyl anthranilate compounds exhibiting anti-fibrotic activity |
| 01/10/2008 | CA2656680A1 Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects |
| 01/10/2008 | CA2656633A1 Substituted benzoxepinoisoxazoles and the use thereof |
| 01/10/2008 | CA2656630A1 Aqueous pharmaceutical formulation of 4-[((4-carboxybutyl)-{2-[(4-phenethyl-benzyl)oxy]-phenethyl}amino)methyl]benzoic acid |
| 01/10/2008 | CA2656265A1 Synthesis of diethyl{ i5" (3 -fluorophenyl) -pyridine-2-yl] methyl} phosphonate used in the synthesis of himbacine analogs |
| 01/10/2008 | CA2654246A1 Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group |
| 01/09/2008 | EP1876239A1 Degranulation inhibitor |
| 01/09/2008 | EP1876238A1 Novel polypeptide and use thereof |
| 01/09/2008 | EP1876233A1 Cells capable of differentiating into cardiac muscle cells |
| 01/09/2008 | EP1876179A1 Thienopyrimidone compound |
| 01/09/2008 | EP1874775A2 Triazolophthalazines as pde2-inhibitors |
| 01/09/2008 | EP1874774A1 Combination product |
| 01/09/2008 | EP1874349A2 Use of cd25 antibodies in immunotherapy |
| 01/09/2008 | EP1874340A2 Elastin protective polyphenolics and methods of using the same |
| 01/09/2008 | EP1874329A1 Blood pressure lowering protein hydrolysates |
| 01/09/2008 | EP1874322A1 Use of tafi inhibitors for enhanced myocardial reperfusion and facilitated pci |
| 01/09/2008 | EP1874309A1 Roflumilast for the treatment of pulmonary hypertension |
| 01/09/2008 | EP1874306A1 Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
| 01/09/2008 | EP1874289A2 Reduction in complement activation and inflammation during tissue injury by carotenoids, carotenoid analogs, or derivatives thereof |
| 01/09/2008 | EP1874223A2 Elastin stabilization of connective tissue |
| 01/09/2008 | EP1874140A1 Peptides having a health benefit and compositions comprising them |
| 01/09/2008 | EP1620409B1 Quinoxalin-3-one derivatives as orexin receptor antagonists |
| 01/09/2008 | EP1527068B1 Novel arylimidazole derivatives, their use as no-syntase inhibitors and as modulators of sodium channels |
| 01/09/2008 | EP1460084B1 Novel peptide sy |
| 01/09/2008 | EP1409449B1 Alpha-ketoglutarates of active ingredients and compositions containing same |
| 01/09/2008 | EP1400513B1 Unsymmetrical cyclic diamine compound |
| 01/09/2008 | EP1385845B1 N-aroyl cyclic amines |
| 01/09/2008 | EP1324766B1 Fgf-2 for the treatment of peripheral artery disease |
| 01/09/2008 | EP1311270B1 Non-sedating barbiturate compounds as neuroprotective agents |
| 01/09/2008 | EP1283043B1 Ophthalmic solution |
| 01/09/2008 | EP1263730B1 Amine derivatives for the treatment of apoptosis |
| 01/09/2008 | EP1254176B1 Use of the extracellular domain of TRADE molecules in medicaments for treating neoplasia |
| 01/09/2008 | EP1239877B1 Composition comprising a tnf-alpha inhibitor and an integrin alphavbeta3 receptor antagonist |
| 01/09/2008 | EP1176956B1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 01/09/2008 | EP1044009B1 Methods and compositions employing red rice fermentation products |
| 01/09/2008 | CN101103033A Triazolophthalazines as PDE2-inhibitors |
| 01/09/2008 | CN101103030A Medicaments with HM74A receptor activity |
| 01/09/2008 | CN101103015A 5-thioxo-1,5-dihydro-2h-pyrrol-2-one derivatives as liver X receptor modulators |
| 01/09/2008 | CN101103002A 3,4,(5)-substituted tetrahydropyridines |
| 01/09/2008 | CN101102788A Fibrosis inhibitor for implanted organ |
| 01/09/2008 | CN101102775A Methods of using PDEV inhibitors for the treatment of congestive heart failure |
| 01/09/2008 | CN101102774A Intravenous formulations of PDE-5 inhibitors |
| 01/09/2008 | CN101102773A Aminopyrazine analogs for treating glaucoma and other RHO kinase-mediated diseases |
| 01/09/2008 | CN101102768A Method and composition for the treatment of hyperlipidemia |
| 01/09/2008 | CN101102764A Methods of use of dual PPAR agonist compounds and drug delivery devices containing such compounds |
| 01/09/2008 | CN101102758A Thyroid hormone analogs for promoting angiogenesis |
| 01/09/2008 | CN101102755A Use of renin inhibitors for the prevention or treatment of diastolic dysfunction or diastolic heart failure |
| 01/09/2008 | CN101100472A 4-amino-5,6-substituted thiopheno [2,3-D] pyrimidines compound and its uses |
| 01/09/2008 | CN101100458A Bibenzimidazole derivative with PPARgamma exciting agent activity and application thereof |
| 01/09/2008 | CN101099860A Use of erythropoietin |
| 01/09/2008 | CN101099847A Medicine for treating cardiac and cerebral vascular disease |
| 01/09/2008 | CN101099838A Traditional Chinese medicine for treating female menopausal syndrome |
| 01/09/2008 | CN101099836A Traditional Chinese medicine composition for treating ischemic apoplexy and preparation process thereof |
| 01/09/2008 | CN101099828A Soft capsule for reducing blood pressure and improving sleeping |
| 01/09/2008 | CN101099808A Traditional Chinese medicine for treating hemorrhoid |
| 01/09/2008 | CN101099803A Pill-tablet for effective fat-reducing and treating three-high (hyperglycemia, hypertension and hyperlipemia) |
| 01/09/2008 | CN101099775A Cardiac and cerebral vascular disease treating medicine |
| 01/09/2008 | CN101099770A Medicinal composition with imidazoline receptor agonist activity and preparation method and application |
| 01/09/2008 | CN101099762A Blood pressue lowering sustained-release preparation with chrysanthemum flower and pearl |
| 01/09/2008 | CN101099761A Pueraria flavone anti-radiation, anti-fatigue, resisting oxygen deficit and heart protecting action |
| 01/09/2008 | CN101099758A Compound gingko leaves preparation and its preparing process |
| 01/09/2008 | CN101099754A Preparation method and application for pedunculoside II |
| 01/09/2008 | CN101099753A Preparation method and application for general saponin of cortex ilecis rotundae |
| 01/09/2008 | CN101099741A Alprostadil and vitamin F millimicroball composite medicine and its preparation method |
| 01/09/2008 | CN101099734A Agonism of the 5ht2a receptor for treatment of thermoregulatory dysfunction |
| 01/09/2008 | CN101099731A Use of erythropoietin |
| 01/09/2008 | CN101099726A Phentolamine Mesylate freeze-dried powder injection preparation and preparation method thereof |
| 01/09/2008 | CN100360931C Quality control method for red sage root and notoginseng preparation |
| 01/09/2008 | CN100360563C Recombinant VPAC2 receptor specific agonist RMBAY, its expression and use |
| 01/09/2008 | CN100360562C Recombinant VPAC2 receptor specific agonist RMROM, its expression and use |
| 01/09/2008 | CN100360550C Liver X receptor agonists |
| 01/09/2008 | CN100360533C 4-(4-trans-hydroxycyclohexyl)amino-2-phenyl-7h-pyrrolo [2, 3d]pyrimidine hydrogen mesylate and its polymorphic forms |
| 01/09/2008 | CN100360519C Benzothiepine ileal bile acid transport inhibitors |
| 01/09/2008 | CN100360505C Quinazoline derivatives as angiogenesis inhibitors |
| 01/09/2008 | CN100360499C Propanoic acid derivatives that inhibit binding of integrins to their receptors |
| 01/09/2008 | CN100360183C Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 01/09/2008 | CN100360154C Chinese medicine for treating angiitis and phlebitis etc. thromboembolia disease |
| 01/09/2008 | CN100360153C Glucoside extracts from figwort roof, its making method and use in preparing medicines |
| 01/09/2008 | CN100360149C External use medicine for treating hemorrhoid |
| 01/09/2008 | CN100360148C Medicine for treating hemorrhoil |
| 01/09/2008 | CN100360136C Unfermented gel fraction from psyllium seed husks |
| 01/09/2008 | CN100360135C Double-layer delayed-releasing tablet of seudo-ginseng general saponin and production thereof |
| 01/09/2008 | CN100360134C Injection liquid containing alprostadic and its production process |
| 01/09/2008 | CN100360130C 1-(4-piperidinyl) benzimidazolones as histamine H3 antagonists |
| 01/09/2008 | CN100360126C Method for treating ischemic stroke with melatonin |
| 01/09/2008 | CN100360119C Ginseng-monkshood slow-release coating microporous film coated tablet for treating qi asthenia and yang depletion and preparing method thereof |
| 01/09/2008 | CN100360118C Ginseng-monkshood skeleton slow-release hydrophilic gel skeleton tablet for treating qi asthenia and yang depletion and preparing method thereof |
| 01/09/2008 | CN100360115C Molecular coating method of plant polyphenol kind substance |
| 01/08/2008 | USRE40000 Method of treatment for decreasing mortality resulting from congestive heart failure |
| 01/08/2008 | US7317115 Mandelates salts of substituted tetracyclic tetrahydrofuran derivatives |
| 01/08/2008 | US7317077 Neural thread proteins (NTP); antiproliferative agents |
| 01/08/2008 | US7317040 Nitric oxide synthase inhibitor phosphate salt |
| 01/08/2008 | US7317035 Tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 01/08/2008 | US7317034 Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine compounds |
| 01/08/2008 | US7317026 Sleep disorders; side effect reduction ; antihistamine antagonist |
| 01/08/2008 | US7317016 Methods of treating medical conditions using sulfonate-substituted pyrazolopyridine derivatives |
| 01/08/2008 | US7317014 pyrimidine derivatives such as 4-Chloro-5,6-diphenyl-2-(trifluoromethyl)pyrimidine, used for the treatment of inflammation and immunological diseases |
| 01/08/2008 | US7317008 Carotenoid ester analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury |
| 01/08/2008 | US7317005 Cyclic oligopeptide; hypotensive agents; congestive heart failure, antiischemic agents, cirrhosis, kidney failure, strokes; thrombosis |